ALMR
Alamar Biosciences, Inc.
A biotech company that makes ultra-sensitive tools for measuring proteins in blood and other samples. Its NULISA platform lets researchers spot tiny amounts of disease-linked proteins, helping with early cancer detection and drug development. Founded in 2018 by Yuling Luo, who previously co-founded Advanced Cell Diagnostics, Alamar is based in Fremont, California, and grew out of the "next chapter" of ultra-sensitive molecular detection work.
CUSIP: 010911105HealthcareUS2 holders
Total Value
$52.16M
Total Shares
1.97M
Net Share Change
+1.97M
Activity
2 buying
Investor
Value
Shares
Weight
Change
